Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-15
    E.g., 2018-10-15

Archive Search

2 results
3:11 PM, Jun 01, 2018  |  BioCentury | Emerging Company Profile

Scratching the surface

its platform to develop molecules with bactericidal activity against Gram-negative bacteria. At least two companies, A2A Pharmaceuticals LLC
199,851) Investors: Undisclosed angel investors CEO: Ajay Mistry Patents: None issued Companies and Institutions Mentioned  A2A Pharmaceuticals LLC
12:00 AM, Aug 22, 2016  |  BioCentury | Emerging Company Profile

Metal smithing

hours in a mouse model of wild-type E. coli infection. At least one other company, A2A Pharmaceuticals LLC
its own IP covering the LpxC program and its cancer programs. Companies and Institutions Mentioned A2A Pharmaceuticals LLC